SOLOSEC
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 29 Nov 2024)
What this means for you
Registered since 19 Jun 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86696432
- Registration number
- 5498160
- Mark type
- Stylized text
- Filed
- 17 Jul 2015
- Published for opposition
- 08 Mar 2016
- Registered
- 19 Jun 2018
- Attorney of record
- Neil A. Salyards
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and biological preparations used in the treatment of women's health infections
Owner
- EVOFEM BIOSCIENCES, INC., SAN DIEGO, CA, US
- LUPIN INC., NAPLES, FL, US
- Symbiomix Therapeutics, LLC, Newark, NJ, US
- Symbiomix Therapeutics, LLC, Newark, NJ, US
- Symbiomix Therapeutics, LLC, Newark, NJ, US
Prosecution history
- 29 Nov 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 29 Nov 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 29 Nov 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 11 Sept 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 30 Jul 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jul 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jul 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 18 Jun 2024 — TEAS SECTION 8 & 15 RECEIVED
- 19 Jun 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Mar 2021 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 19 Jun 2018 — REGISTERED-PRINCIPAL REGISTER
- 16 May 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 May 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 May 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 23 Apr 2018 — USE AMENDMENT FILED